Filed: 11/14/2024ACC: 0000950123-24-011486
📋 What this filing means
OMEGA FUND MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 11 equity positions with a total reported market value of $160.01M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
11
Positions
$160.01M
Total AUM (reported)
27.28M
Total Shares
Allocation by class
COMMON STOCK$129.40M80.9%
COMMON STOCK CLASS A$29.94M18.7%
WARRANT$675.2K0.4%
Portfolio Concentration
Top 3$113.06M70.7%
4–10$46.40M29.0%
11–25$540.2K0.3%
Top 3 weight
70.7%
Top 10 weight
99.7%
Voting Authority Distribution
Total shares with voting rights: 27.28M
Sole
Full voting authority
27.28M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole11
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings11
Rows:
Bicara Therapeutics Inc.
SOLEShares2.20M
TypeSH
Market value$56.15M
35.09%
Sole
2.20M
Shared
0.00
None
0.00
Nuvation Bio
SOLEShares13.07M
TypeSH
Market value$29.94M
18.71%
Sole
13.07M
Shared
0.00
None
0.00
Replimune Group
SOLEShares2.46M
TypeSH
Market value$26.98M
16.86%
Sole
2.46M
Shared
0.00
None
0.00
Lexeo Therapeutics
SOLEShares2.36M
TypeSH
Market value$21.30M
13.31%
Sole
2.36M
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares1.08M
TypeSH
Market value$7.10M
4.44%
Sole
1.08M
Shared
0.00
None
0.00
Alumis Inc
SOLEShares653.22K
TypeSH
Market value$6.98M
4.36%
Sole
653.22K
Shared
0.00
None
0.00
Ikena Oncology
SOLEShares2.25M
TypeSH
Market value$3.89M
2.43%
Sole
2.25M
Shared
0.00
None
0.00
Sana Biotechnology, Inc.
SOLEShares843.75K
TypeSH
Market value$3.51M
2.19%
Sole
843.75K
Shared
0.00
None
0.00
Immunic Inc
SOLEShares1.79M
TypeSH
Market value$2.95M
1.84%
Sole
1.79M
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares321.50K
TypeSH
Market value$675.2K
0.42%
Sole
321.50K
Shared
0.00
None
0.00
Syros Pharmaceuticals
SOLEShares251.27K
TypeSH
Market value$540.2K
0.34%
Sole
251.27K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Bicara Therapeutics Inc.SOLE | Common Stock | 2.20M | SH | $56.15M 35.09% | 2.20M | 0.00 | 0.00 |
Nuvation BioSOLE | Common Stock Class A | 13.07M | SH | $29.94M 18.71% | 13.07M | 0.00 | 0.00 |
Replimune GroupSOLE | Common Stock | 2.46M | SH | $26.98M 16.86% | 2.46M | 0.00 | 0.00 |
Lexeo TherapeuticsSOLE | Common Stock | 2.36M | SH | $21.30M 13.31% | 2.36M | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Common Stock | 1.08M | SH | $7.10M 4.44% | 1.08M | 0.00 | 0.00 |
Alumis IncSOLE | Common Stock | 653.22K | SH | $6.98M 4.36% | 653.22K | 0.00 | 0.00 |
Ikena OncologySOLE | Common Stock | 2.25M | SH | $3.89M 2.43% | 2.25M | 0.00 | 0.00 |
Sana Biotechnology, Inc.SOLE | Common Stock | 843.75K | SH | $3.51M 2.19% | 843.75K | 0.00 | 0.00 |
Immunic IncSOLE | Common Stock | 1.79M | SH | $2.95M 1.84% | 1.79M | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Warrant | 321.50K | SH | $675.2K 0.42% | 321.50K | 0.00 | 0.00 |
Syros PharmaceuticalsSOLE | Common Stock | 251.27K | SH | $540.2K 0.34% | 251.27K | 0.00 | 0.00 |